000 01510 a2200409 4500
005 20250516195145.0
264 0 _c20141113
008 201411s 0 0 eng d
022 _a1542-6270
024 7 _a10.1177/1060028014521389
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDoré, Maxime
245 0 0 _aFebuxostat as a novel option to optimize thiopurines' metabolism in patients with inadequate metabolite levels.
_h[electronic resource]
260 _bThe Annals of pharmacotherapy
_cMay 2014
300 _a648-51 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAzathioprine
_xadministration & dosage
650 0 4 _aDrug Interactions
650 0 4 _aEnzyme Inhibitors
_xadministration & dosage
650 0 4 _aFebuxostat
650 0 4 _aFemale
650 0 4 _aGuanine Nucleotides
_xblood
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aMercaptopurine
_xanalogs & derivatives
650 0 4 _aMuscular Diseases
_xdrug therapy
650 0 4 _aThiazoles
_xadministration & dosage
650 0 4 _aThionucleotides
_xblood
650 0 4 _aXanthine Oxidase
_xantagonists & inhibitors
700 1 _aFrenette, Anne Julie
700 1 _aMansour, Anne-Marie
700 1 _aTroyanov, Yves
700 1 _aBégin, Josiane
773 0 _tThe Annals of pharmacotherapy
_gvol. 48
_gno. 5
_gp. 648-51
856 4 0 _uhttps://doi.org/10.1177/1060028014521389
_zAvailable from publisher's website
999 _c23541618
_d23541618